Open calls

IMI2 - Call 22
Launched on 23 June 2020
Restricted Call to maximise impact of IMI2 JU objectives and scientific priorities
IMI2 - Call 23
Launched on 23 June 2020
Topics on tackling cancer through artificial intelligence, antimicrobial resistance, neurodegenerative diseases, rare disease diagnosis, the return of clinical trial data to participants, and patient adherence
IMI2 - Call 21
Launched on 3 March 2020
Development of therapeutics and diagnostics combatting coronavirus infections
IMI2 - Call 20
Launched on 21 January 2020
Topics on psoriatic arthritis, vaccines, tuberculosis, tumour plasticity, proton vs photon therapy, and protein drug products
IMI2 - Call 18
Launched on 26 June 2019
Topics on advanced therapy medicinal products (ATMPs), digital pathology and artificial intelligence, healthcare information, health outcomes, and patient-reported outcomes